Drug · DIN 02236997
LYDERM
Yes: authorized and sold in Canada
Authorized, and the company reports that it sells it in Canada.
Status Marketed since December 7, 2023; first marketed April 27, 1998.
- Drug Identification Number (DIN)
- 02236997
- Company (DIN owner)
- Taropharma, A Division Of Taro Pharmaceuticals Inc.Brampton, Ontario, Canada
- Schedule
- Prescription
- Dosage form
- Gel
- Route
- Topical
- Therapeutic class (ATC)
- Fluocinonide D07AC08
- Class
- Human
- Record last updated
- March 22, 2025
Active ingredients
As listed in the Drug Product Database.
| Ingredient | Strength | Per |
|---|---|---|
| FLUOCINONIDE | 0.05 % |
Notices of Compliance
Health Canada approvals that name this DIN.
- December 7, 2023: NOC 32302Supplement to an Abbreviated New Drug Submission (SANDS) · Administrative: Product Name Change. Update to the Product Monograph. Update to Labels
- September 4, 2003: NOC 797Abbreviated New Drug Submission (ANDS) · Manufacturer name change
- January 31, 2001: NOC 2279Abbreviated New Drug Submission (ANDS) · Manufacturer name change
- December 8, 1997: NOC 3808Supplement to an Abbreviated New Drug Submission (SANDS) · New dosage forms - ointment and gel
Other DINs named LYDERM
- DIN 00716863 · Marketed
- DIN 02236996 · Marketed